Baby Cough Medicine Recalled for Improper Storage Temperature
Zarbee's Naturals baby cough syrup has been recalled due to storage temperature deviations at Family Dollar stores between April and June 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses, injuries, or hospitalizations. The hazard is improper storage handling rather than confirmed product contamination, making it a precautionary manufacturing-deviation recall.
Plain-English summary
Zarbee's Naturals baby cough medicine in 2 fl oz bottles distributed by Family Dollar Stores, LLC has been recalled. The product was held outside appropriate storage temperature conditions, which constitutes a Current Good Manufacturing Practice (CGMP) deviation.
The affected bottles were distributed to specific Family Dollar stores nationwide between April 30, 2022 and June 10, 2022. The product is identified by SKU 999984.
The recalled product
- Product
- ZARBEES NTRLS BABY CGH MUCUS GRP 2 FL OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Cough / Cold Medicine
- Hazard
- improper-storage
- temperature-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 999984
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01